XML 33 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total IBM Stockholders' Equity
Common Stock and Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Non-Controlling Interests
Total
Balance at the Beginning of the Period at Dec. 31, 2017 $ 17,594 $ 54,566 $ 153,126 $ (163,507) $ (26,592) $ 131 $ 17,725
Equity              
Cumulative effect of change in accounting principle | Accounting Standards Update 2014-09, Revenue from Contracts with Customers 524   524       524
Cumulative effect of change in accounting principle | Accounting Standards Updates 2016-01 (Financial Instruments), 2017-12 (Hedging) and 2018-02 (Stranded Tax Effects) [1]     2,422   (2,422)    
Net income plus other comprehensive income/(loss):              
Net income 6,777   6,777       6,777
Other comprehensive income/(loss) 1,194       1,194   1,194
Total comprehensive income/(loss) 7,970           7,970
Cash dividends paid - common stock (4,250)   (4,250)       (4,250)
Common stock issued under employee plans 421 421         421
Purchases and sales of treasury stock under employee plans - net (89)   13 (101)     (89)
Other treasury shares purchased, not retired (2,388)     (2,388)     (2,388)
Changes in noncontrolling interests           3 3
Balance at the End of the Period at Sep. 30, 2018 19,784 54,987 158,612 (165,995) (27,820) 134 19,918
Balance at the Beginning of the Period at Dec. 31, 2017 17,594 54,566 153,126 (163,507) (26,592) 131 17,725
Balance at the End of the Period at Dec. 31, 2018 16,796 55,151 159,206 (168,071) (29,490) 134 16,929
Balance at the Beginning of the Period at Jun. 30, 2018 18,520 54,827 157,349 (165,366) (28,290) 128 18,648
Net income plus other comprehensive income/(loss):              
Net income 2,694   2,694       2,694
Other comprehensive income/(loss) 470       470   470
Total comprehensive income/(loss) 3,164           3,164
Cash dividends paid - common stock (1,431)   (1,431)       (1,431)
Common stock issued under employee plans 160 160         160
Purchases and sales of treasury stock under employee plans - net (2)   1 (3)     (2)
Other treasury shares purchased, not retired (627)     (627)     (627)
Changes in noncontrolling interests           6 6
Balance at the End of the Period at Sep. 30, 2018 19,784 54,987 158,612 (165,995) (27,820) 134 19,918
Balance at the End of the Period at Dec. 31, 2018 16,796 55,151 159,206 (168,071) (29,490) 134 16,929
Net income plus other comprehensive income/(loss):              
Net income 5,761   5,761       5,761
Other comprehensive income/(loss) 404       404   404
Total comprehensive income/(loss) 6,165           6,165
Cash dividends paid - common stock (4,269)   (4,269)       (4,269)
Common stock issued under employee plans 657 657         657
Purchases and sales of treasury stock under employee plans - net (56)   16 (72)     (56)
Other treasury shares purchased, not retired (1,331)     (1,331)     (1,331)
Changes in other equity (5)   (5)       (5)
Changes in noncontrolling interests           6 6
Balance at the End of the Period at Sep. 30, 2019 17,956 55,808 160,709 (169,474) (29,086) 139 18,096
Balance at the Beginning of the Period at Jun. 30, 2019 17,645 55,404 160,467 (169,385) (28,841) 131 17,776
Net income plus other comprehensive income/(loss):              
Net income 1,672   1,672       1,672
Other comprehensive income/(loss) (245)       (245)   (245)
Total comprehensive income/(loss) 1,427           1,427
Cash dividends paid - common stock (1,436)   (1,436)       (1,436)
Common stock issued under employee plans 404 404         404
Purchases and sales of treasury stock under employee plans - net 32   6 27     32
Other treasury shares purchased, not retired (115)     (115)     (115)
Changes in noncontrolling interests           8 8
Balance at the End of the Period at Sep. 30, 2019 $ 17,956 $ 55,808 $ 160,709 $ (169,474) $ (29,086) $ 139 $ 18,096
[1] * Reflects the adoption of the FASB guidance on stranded tax effects, hedging and financial instruments. Refer to note 2, “Accounting Changes.”